万维提示：
1、投稿方式：在线投稿。
2、期刊网址：http://sfrrj.umin.jp/JCBN.htm
https://www.jstage.jst.go.jp/browse/jcbn/
3、投稿网址：http://www.editorialmanager.com/jcbn/
4、官网邮箱：jcbn@nacos.com
toyokuni@med.nagoya-u.ac.jp（主编）
更多编辑邮箱请查看期刊官网信息。
5、期刊刊期：双月刊，一年出版6期。
2021年8月24日星期二
投稿须知【官网信息】
Journal of Clinical Biochemistry and Nutrition
The Official Journal of the Society for Free Radical Research Japan INSTRUCTION TO AUTHORS
AIMS & SCOPE
Journal of Clinical Biochemistry and Nutrition (JCBN) is an international, interdisciplinary publication encompassing chemical, biochemical, physiological, pathological, toxicological and medical approaches to research on lipid peroxidation, free radicals, oxidative stress and nutrition. The Journal welcomes original contributions dealing with all aspects of clinical biochemistry and clinical nutrition including both in vitro and in vivo studies.
PUBLICATIONS
Original Articles: Peer-reviewed, high-quality, concise research investigations that represent new and significant contributions to science.
Review Articles: Reviews of major areas or sub-areas in clinical biochemistry and clinical nutrition. These articles are peer-reviewed. Articles may be of any length.
Serial Reviews: A collection of normally invited reviews on a specific topic.
Letters to the Editor: Letters dealing with published articles or matters of interest to free radical researchers are invited.
They should be short (not more than 400 words), typed double-spaced, and include references where appropriate.
Where a published article is involved, the original author(s) will be invited to submit a response.
Announcements and Calendar: Providing notices of forthcoming meetings, courses, and other events relevant to clinical biochemistry and clinical nutrition researchers. All such items will be listed (free of charge) in the journal issues preceding the event and will be updated upon request.
EDITORIAL REVIEW and ACCEPTANCE
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed by two anonymous reviewers,
the Referee selected by Executive Editors, and the Editor.
Final acceptance or rejection rests with the Editor-in-Chief, who reserves the right to refuse any material for publication.
Authors may present names of potential reviewers and of reviewers whom they would prefer not to review the manuscript. The choice of reviewers remains the Editor’s prerogative. A manuscript requiring revision will be returned to the author by email, along with specific suggestions for revision. Authors should follow the instructions below to submit revised manuscripts:
• The author should reply to the suggestions clearly in the “Author’s Response” section by indicating places where revisions have been made, and/or by stating reasons for disregarding other suggestions if they are thought to be unacceptable.
• Modified parts should be highlighted using underline or colored font.
Manuscripts should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. They should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editor and the Publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and to improve communication between author and reader. If extensive alterations are required, the manuscript will be returned to the author for revision.
……
更多详情：
http://sfrrj.umin.jp/data/63-1-Instruction.pdf
